Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22752L |
(D-Ser2)-Leu-Enkephalin-Thr
|
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
(D-Ser2)-Leu-Enkephalin-Thr 是阿片受体的 delta 选择性药物,具有镇痛作用。 | |||
T9446 |
KB-0742 dihydrochloride
|
CDK | Cell Cycle/Checkpoint |
KB-0742 dihydrochloride 是一种有效的、选择性的、口服的 CDK9 抑制剂,具有抗肿瘤活性,对CDK9/cyclin T1的IC50为 6 nM。它对CDK9/cyclin T1具有选择性,其选择性是其他 CDK 激酶的 50 倍以上。 | |||
TP1641 |
[pSer2, pSer5, pSer7]-CTD TFA
|
||
[pSer2, pSer5, pSer7]-CTD (TFA) is a substrate for CDK7(cyclin-dependent protein kinase), a phosphorylated polypeptide at ser2, ser5, and ser7 of RNA polymerase II carboxyl terminus (CTD). | |||
TP1683 |
[pSer2, pSer5, pSer7]-CTD
|
||
[pSer2, pSer5, pSer7]-CTD is a substrate for CDK7(cyclin-dependent protein kinase), a phosphorylated polypeptide at ser2, ser5, and ser7 of RNA polymerase II carboxyl terminus (CTD). | |||
T82758 |
CDK9-Cyclin T1 PPI-IN-1
|
CDK | Cell Cycle/Checkpoint |
CDK9-Cyclin T1 PPI-IN-1 (Compound B19) 是CDK9-Cyclin T1蛋白-蛋白相互作用的选择性抑制剂。该化合物能够有效抑制TNBC MDA-MB-231细胞系的细胞增殖(IC50: 0.044 μM),诱导细胞凋亡,同时降低CDK9的转录活性并减少RNA Pol II CTD ser2的磷酸化,有效地抑制了4T1移植瘤模型小鼠中肿瘤的生长。 | |||
T70953 |
AZ5576 racemate
|
||
AZ5576 racemate is a racemic mixture of AZ5576 isomers. AZ5576 is a potent, highly selective, and orally bioavailable inhibitor of Cdk9 that inhibits Cdk9 enzyme activity with an IC50 <5nM and decreases phosphorlyation of Ser2-RNAPII in cells with an IC50 of 96nM. In the MLL-fusion containing acute myeloid leukemia (AML) line, MV411, short-term treatment with AZ5576 led to a rapid dose-dependent decrease in pSer2-RNAPII with concomitant loss of Mcl1 mRNA and protein, resulting in the cleavage a... |